Results 231 to 240 of about 9,693,931 (354)

Viral Metagenomics for the Identification of Emerging Infections in Clinical Samples with Inconclusive Dengue, Zika, and Chikungunya Viral Amplification. [PDF]

Viruses, 2022
Souza JVC, Santos HO, Leite AB, Giovanetti M, Bezerra RDS, Carvalho E, Bernardino JST, Viala VL, Haddad R, Ciccozzi M, Alcantara LCJ, Sampaio SC, Covas DT, Kashima S, Elias MC, Slavov SN.   +15 more
europepmc   +1 more source

Ofatumumab Therapy and Long‐Term Seizure Outcomes of Patients With Relapsing Anti‐NMDA Receptor Encephalitis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective There is a lack of studies on seizure outcomes associated with ofatumumab therapy in patients for relapsing anti‐N‐methyl‐D‐aspartate (NMDA) receptor encephalitis. We aimed to evaluate long‐term seizure outcomes of ofatumumab therapy for relapsing anti‐NMDA receptor encephalitis.
Jian Wang, Mengjiao Li, Ping Kong
wiley   +1 more source

Clinician Management Preferences for <i>Clostridioides difficile</i> Infection in Adults: A 2024 Emerging Infections Network Survey. [PDF]

Open Forum Infect Dis
Boton N, Patel PK, Beekmann SE, Polgreen PM, Buckel WR, Mahoney MV, Mehrotra P, Lee MSL.   +7 more
europepmc   +1 more source

Emerging Infections Due to Shewanella spp.: A Case Series of 128 Cases Over 10 Years. [PDF]

Front Med (Lausanne), 2022
Ng WW, Shum HP, To KK, Sridhar S.
europepmc   +1 more source

Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The glucagon‐like peptide‐1 (GLP‐1) receptor agonists (RAs) are a relatively new class of drugs that were initially approved by the US Food and Drug Administration to improve glycemic control in patients with type 2 diabetes mellitus and, subsequently, weight reduction in patients with obesity.
Audrey Y. Chang, Farrah J. Mateen
wiley   +1 more source

Partial Oral Therapy for Infective Endocarditis Among Adult Infectious Diseases Physicians in the United States: An Emerging Infections Network Survey. [PDF]

Open Forum Infect Dis
McHugh JW, Baddour LM, Chesdachai S, Beekmann SE, Polgreen PM, Wilson WR, DeSimone DC.   +6 more
europepmc   +1 more source

Artificial Intelligence–Based Online Symptom Assessment Tools for Systemic Lupus Erythematosus Diagnosis: Patient Perspectives

Arthritis Care &Research, EarlyView.
Objective The objective of this article is to identify perceptions of patients with systemic lupus erythematosus (SLE) regarding artificial intelligence (AI)–based online symptom assessment tools, and the potential of these tools to address diagnostic barriers.
Olivia A. Stein, Jennifer L. F. Lee, Evelyne Vinet, Arielle Mendel, Christian A. Pineau, Fares Kalache, Louis‐Pierre Grenier, Sasha Bernatsky   +7 more
wiley   +1 more source

Redesigning Surveillance through the Global Emerging Infections Surveillance Program. [PDF]

Emerg Infect Dis
Brett-Major DM.
europepmc   +1 more source

Immunosuppressive Drug Use in Limited Systemic Sclerosis: An International Survey

Arthritis Care &Research, EarlyView.
Objective Current guidelines recommend immunosuppressive treatment for diffuse cutaneous systemic sclerosis but are less clear on their use in limited cutaneous systemic sclerosis (lcSSc) in the absence of internal organ complications. We conducted an international survey to understand current immunosuppressive drug prescribing patterns in lcSSc ...
Sabrina Hoa, Yicheng Mu, Marie Hudson, Janet Pope   +3 more
wiley   +1 more source

Global Emerging Infections Surveillance Program Contributions to Pandemic Preparedness and Response. [PDF]

Emerg Infect Dis
Creppage KE, Gallaway MS, Russell DA, Early JM, Smith HJ, Mooney AC, Hydrick AM, Kasper MR.   +7 more
europepmc   +1 more source